Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Tuberculosis

  Free Subscription


11.10.2021

2 Antimicrob Agents Chemother
1 Clin Infect Dis
1 Infect Immun
6 PLoS One
1 Trop Med Int Health


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. GANAPATHY US, Del Rio RG, Cacho-Izquierdo M, Ortega F, et al
    A Mycobacterium tuberculosis NBTI DNA gyrase inhibitor is active against Mycobacterium abscessus.
    Antimicrob Agents Chemother. 2021 Oct 4:AAC0151421. doi: 10.1128/AAC.01514.
    PubMed         Abstract available

  2. RADTKE KK, Ernest JP, Zhang N, Ammerman NC, et al
    Comparative efficacy of rifapentine alone and in combination with isoniazid for latent tuberculosis infection: a translational pharmacokinetic-pharmacodynamic modelling study.
    Antimicrob Agents Chemother. 2021 Oct 4:AAC0170521. doi: 10.1128/AAC.01705.
    PubMed         Abstract available


    Clin Infect Dis

  3. IMPERIAL MZ, Nedelman JR, Conradie F, Savic RM, et al
    Proposed linezolid dosing strategies to minimize adverse events for treatment of extensively drug-resistant tuberculosis.
    Clin Infect Dis. 2021 Oct 4. pii: 6380680. doi: 10.1093.
    PubMed         Abstract available


    Infect Immun

  4. ERIBO OA, du Plessis N, Chegou NN
    THE INTESTINAL COMMENSAL, Bacteroides fragilis, MODULATES HOST RESPONSES TO VIRAL INFECTION AND THERAPY: LESSONS FOR EXPLORATION DURING Mycobacterium tuberculosis INFECTION.
    Infect Immun. 2021 Oct 4:IAI0032121. doi: 10.1128/IAI.00321.
    PubMed         Abstract available


    PLoS One

  5. DOLLA CK, Dhanaraj B, Chandrasekaran P, Selvaraj S, et al
    Prevalence of bacteriologically confirmed pulmonary tuberculosis and associated risk factors: A community survey in Thirvallur District, south India.
    PLoS One. 2021;16:e0247245.
    PubMed         Abstract available

  6. WELEKIDAN LN, Skjerve E, Dejene TA, Gebremichael MW, et al
    Correction: Characteristics of pulmonary multidrug-resistant tuberculosis patients in Tigray Region, Ethiopia: A cross-sectional study.
    PLoS One. 2021;16:e0258457.
    PubMed         Abstract available

  7. SUN L, Chen Y, Yi P, Yang L, et al
    Serological detection of Mycobacterium Tuberculosis complex infection in multiple hosts by One Universal ELISA.
    PLoS One. 2021;16:e0257920.
    PubMed         Abstract available

  8. SANCHEZ-CORRALES L, Tovar-Aguirre OL, Galeano-Vanegas NF, Castano Jimenez PA, et al
    Phylogenomic analysis and Mycobacterium tuberculosis antibiotic resistance prediction by whole-genome sequencing from clinical isolates of Caldas, Colombia.
    PLoS One. 2021;16:e0258402.
    PubMed         Abstract available

  9. DIRIBA G, Tola HH, Alemu A, Yenew B, et al
    Drug resistance and its risk factors among extrapulmonary tuberculosis in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0258295.
    PubMed         Abstract available

  10. VON BOTH U, Gerlach P, Ritz N, Bogyi M, et al
    Management of childhood and adolescent latent tuberculous infection (LTBI) in Germany, Austria and Switzerland.
    PLoS One. 2021;16:e0250387.
    PubMed         Abstract available


    Trop Med Int Health

  11. SOLOMOS Z, Botsi C, Georgakopoulou T, Lytras T, et al
    Active case finding of pulmonary TB in a European refugee camp: lessons learnt from Oinofyta hosting site in Greece.
    Trop Med Int Health. 2021;26:1068-1074.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: